Replies to post #357519 on Innovation Pharmaceuticals Inc (IPIX)

[bradfordbros]

I am not sure that is such a bad thing. In fact the opposite as it elevates the conversation and maybe at long last non-peptidic defensin-mimetic new class of drug will come to everybody’ s attention.

[TheDane]

Nothing else to do? Pitiful! Go Leo!

[LIVED]

This has no impact on Brilacidin at all....in April, Merck and Ridgeback announced that it would end their trial of molnupiravir in hospitalized patients because the data showed it was unlikely to help.

[Justfactsmam]

Seems as though you are worried about BP therapeutic competition.

Pfizer has one . . . Merck does too!

...What will the competitive landscape look like in July/August when IPIX finishes their trial?

The other BP therapeutic candidates have to prove safety & efficacy out
...Just as Brilacidin does.

The other BP therapeutic candidates mechanisms...are one dimensional...
...Unlike Brilacidin...which is a three prong mechanism of attack on Covid and its secondary symptons

No matter how much money, influence, bribery that might go on ... the GREAT EQUALIZER is "THE SCIENCE"...the Science of these Products and their Mechanisms are what they are, it WORKS OR IT DOESN'T...

BP and IPIX have to put their pants on in the AM in the same way...its the SCIENCE...and I'll pit the DeGradon Science up against any BP Corporate rushed/forced science any day.

BP's candidates can't be deemed successful and get approval by "IDENTIFYING AS A 'THERAPEUTIC'"... ("me be a Covid therapeutic, bro!").

THIS is not Fantasy island...if they don't have the SCIEINCE (and all other BPs have not, and have failed) BP will FAIL ONCE AGAIN...or at least not be in the same league when Brilacidin succeeds...

The other BP candidates have fallen with load "THUDS"...
...Brilacidin has been constantly one of the "last men standing"

BP has to beat Brilaicidin...

IMO it won't come close...even with the "Great 'Fauci' Houdini" holding them up.